Related article in
Real-world insights into the management of hemophilia A in Italy: treatment patterns and healthcare resource utilization
Valentina Perrone1, Melania Leogrande1, Maria Cappuccilli1 and Luca Degli Esposti1* 
Blood Res 2024; 59(): ~
DOI:https://doi.org/10.1007/s44313-024-00034-6
-
ArticleSeptember 30, 1995
0
352
184
A Case of Idiopathic Thrombocytopenic Purpura in HIV-infected Hemophiliac
Jong Weon Choi, Jin Tae Suh, Yong Mook Choi
Korean J Hematol 1995; 30(3): 479-485 -
Original ArticleDecember 31, 2014
3
2165
617
Progress of
in vitro factor VIII coagulant activity from 0 to 8 hours after reconstitutionYe Jee Shim, Kun Soo Lee, Uk Hyun Kim, Jin Kyung Suh, Sae Yun Baik, and Shin Young Hyun
Blood Res 2014; 49(4): 265-269 -
Original ArticleDecember 31, 2015
8
2818
652
Immune tolerance induction in patients with severe hemophilia A with inhibitors
Ji Eun Ryu, Young Shil Park, Ki Young Yoo, Kyoo Duck Lee, and Yong-Mook Choi
Blood Res 2015; 50(4): 248-253 -
Original ArticleJune 25, 2015
6
2612
546
Human coagulation factor VIII domain-specific recombinant polypeptide expression
Su Jin Choi, Ki Jung Jang, Jeong-A Lim, and Hye Sun Kim
Blood Res 2015; 50(2): 103-108 -
Original ArticleMarch 31, 2016
5
2228
542
Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center
Ki Young Yoo, Sang Chun Joo, and Yong Mook Choi
Blood Res 2016; 51(1): 37-43 -
Original ArticleMarch 31, 2018
3
3967
816
Global hemostatic assay of different target procoagulant activities of factor VIII and factor IX
Ki-Young Yoo, Soo-Young Jung, Sung-Ho Hwang, Su-Min Lee, Jong-Ho Park, and Hyun-Ja Nam
Blood Res 2018; 53(1): 41-48 -
Original ArticleSeptember 30, 2019
3
2816
664
Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients
Chur Woo You, Hee Jo Baek, Sang Kyu Park, Young Shil Park, Ho-Jin Shin, Werner Engl, Srilatha Tangada
Blood Res 2019; 54(3): 198-203 -
Original ArticleSeptember 30, 2019
12
4153
1270
The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A
Ju Young Kim, Chur Woo You
Blood Res 2019; 54(3): 204-209 -
Original ArticleSeptember 30, 2021
2
2837
509
Clinical Analysis of Hospitalized Patients with Hemophilia A: Single-hemophilia Treatment Center Experience in Korea over 10 years
Ju Young Kim, Se Jin Park, Chur Woo You
Blood Res 2021; 56(3): 141-149 -
Original ArticleDecember 31, 2022
2
1961
511
FVIII inhibitor surveillance in children with hemophilia A in Indonesia: a report from the Indonesian Pediatric Hematology-Oncology Working Group
Novie A. Chozie, Djajadiman Gatot, Bambang Sudarmanto, Susi Susanah, Rini Purnamasari, Pudjo Hagung Widjajanto, Susanto Nugroho, Olga Rasiyanti, Dian Puspitasari, Muhammad Riza, Maria C. Shanty Larasati, Sri Suryo Adiyanti, Made Citra Saraswati, Fitri Primacakti, on behalf of the Pediatric Hematology-Oncology Working Group of the Indonesian Pediatric Society
Blood Res 2022; 57(4): 272-277 -
RESEARCHMay 14, 2024
1
1047
73
Assessment of the phenotypic severity of hemophilia A: using rotational thromboelastometry (ROTEM) and APTT-clot waveform analysis
Deepika Gupta, Vandana Arya, Jasmita Dass, Nitin Gupta, Manas Kalra, Anupam Sachdeva and Jyoti Kotwal
Blood Res (2024) 59:19 -
RESEARCHAugust 29, 2024
0
485
79
Evaluation of FVIII pharmacokinetic profiles in Korean hemophilia A patients assessed with myPKFiT: a retrospective chart review
Young-Shil Park
Blood Res (2024) 59:29, Ki-Young Yoo , Sang Kyu Park , Taiju Hwang , Aeran Jung and Eun Jin Choi -
RESEARCHOctober 18, 2024
0
340
35
Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors
Sung Eun Kim, Ji Yoon Kim, Jeong A Park, Chuhl Joo Lyu, Seung Min Hahn, Jung Woo Han and Young Shil Park
Blood Res (2024) 59:34
Most KeyWord
?
What is Most Keyword?
- It is most registrated keyword in articles at this journal during for 2 years.
Most Read
-
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)
Christopher Chin Keong Liam, Jim Yu-Hsiang Tiao, Yee Yee Yap, Yi Lin Lee, Jameela Sathar, Simon McRae, Amanda Davis, Jennifer Curnow, Robert Bird, Philip Choi, Pantep Angchaisuksiri, Sim Leng Tien, Joyce Ching Mei Lam, Doyeun Oh, Jin Seok Kim, Sung-Soo Yoon, Raymond Siu-Ming Wong, Carolyn Lauren, Eileen Grace Merriman, Anoop Enjeti, Mark Smith, Ross Ian Baker
Blood Res 2023;58: 36-41 -
Transfusion support in hematopoietic stem cell transplantation
Dong Wook Jekarl, Jae Kwon Kim, Jay Ho Han, Howon Lee, Jaeeun Yoo, Jihyang Lim, Yonggoo Kim
Blood Res 2023;58: S1-S7
Most Cited
-
Plasmacytoid dendritic cell neoplasms
Yoo Jin Lee, Youjin Kim, Sang Hyuk Park, Jae-Cheol Jo
Blood Res 2023;58: S90-S95 -
Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
Eun-Ji Choi
Blood Res 2023;58: S29-S36
Editorial Office
+82-2-516-6582
